Table 3.

DCCT Treatment Effect on Overall Visual QOL using Quantile Regression

	Estimated Difference In Median	t value	P-value
Treatment: Conventional vs. Intensive	−1.0 (−1.7, −0.3)	−2.76	0.0058
Gender: Female vs. Male	−1.3 (−2.0, −0.6)	−3.57	0.0004
Age at DCCT baseline: Per 10 year increase	−0.9 (−1.3, −0.4)	−3.49	0.0005
HbA1c at DCCT Eligibility Per 10% increase	−0.3 (−0.5, −0.1)	−2.97	0.0030
Retinopathy at DCCT baseline:
ETDRS 20/(<)20 vs. 10/10	−0.2 (−1.1, 0.6)	−0.65	0.5834
ETDRS 35/(<)35 vs. 10/10	−0.3 (−1.4, 0.8)	−0.85	0.5710
ETDRS 43/(<)43 vs. 10/10	−2.4 (−5.6, 0.7)	−1.46	0.1260